期刊文献+

Ⅰb~Ⅱb期高危型宫颈癌术前同步放化疗治疗中不同化疗途径的疗效比较

Preoperative con current radiotherapy and chemotherapy for stage Ⅰb~Ⅱb high-risk cervical carcinoma.
下载PDF
导出
摘要 目的观察Ⅰb~Ⅱb期高危型宫颈癌(巨块型、分化差、非鳞癌)术前同步放化疗治疗中不同化疗途径的疗效及不良反应。方法回顾性分析2003年1月~2009年12月我院收治的74例同步放化疗治疗的Ⅰb~Ⅱb期高危型子宫颈癌患者的临床病理资料,根据化疗途径的不同分为两组,动脉化疗(动脉化疗组)38例及静脉化疗(静脉化疗组)36例,并对两组的不良反应和疗效进行比较。结果动脉化疗组中,化疗有效率为82%。静脉化疗组中,化疗有效率为81%。两组比较差异均无统计学意义(P>0.05)。化疗期间未发现不能耐受的不良反应。动脉化疗组3年盆腔复发率、5年生存率分别为7.9%、70%;静脉化疗组3年盆腔复发率、5年生存率分别7.8%、71%,两组分别比较差异均无统计学意义(P>0.05)。结论同步放化疗对Ⅰb~Ⅱb期高危型子宫颈癌治疗是安全有效的。相对介入动脉化疗,静脉化疗使用简便、经济,无需特殊设备,在经济条件较差的地区值得推广。 Objective Observed Ⅰb~Ⅱb of high-risk cervical cancer(bulky,poorly differentiated,non-squamous cell cancer)Preoperative concurrent radiotherapy and chemotherapy in different ways chemotherapy efficacy and toxicicty.Methods A retrospective analysis from January 2003 to December 2009 in Guang′an City People′s Hospital admitted 74 patients with concurrent radiotherapy and chemotherapy of Ⅰb~Ⅱb cervical cancer patients of high risk clinical and pathological data,according to the different ways chemotherapy is divided into two groups,arterial infusion chemotherapy(artery chemotherapy group) 38 cases and intravenous chemotherapy(intravenous chemotherapy group)36 cases,and toxicity of the two groups and the effects were compared.Results In the artery chemotherapy group,the effective rate was 82%.While in the venous chemotherapy group,the effective rate was 81%.The differences between these two groups showed no significance(P0.05).No intolerable toxic and adverse effects were noticed during concurrent radiotherapy and chemotherapy.The 3-year pelvic recurrence rate and 5-year survival rates of arterial interventional chemotherapy group were 76%,70% respectively,and those of venous chemotherapy group were 7.8%,71% respectively,without significant difference(P0.05).Conclusion Concurrent radiotherapy and chemotherapy is a safe and effective means for treating patients with Ⅰb~Ⅱb of high-risk cervical cancer.The therapeutical effects of venous and arterial interventional chemotherapy are similar.Venous administration is easy and inexpensive and less demanding for special equipments.It shows promising prospect in clinical application especially in the area with poor economic conditions.
作者 罗海全
机构地区 广安市人民医院
出处 《四川医学》 CAS 2010年第11期1656-1658,共3页 Sichuan Medical Journal
关键词 宫颈肿瘤 同步放化疗 化学疗法 辅助 输注 动脉内 输注 静脉内 cervix neoplasms concurrent radiotherapy and chemotherapy chemotherapy adjurant infusions intra-arterial infusions intra-venous
  • 相关文献

参考文献8

  • 1李丽玲.同步放化疗在宫颈癌治疗中的应用[J].医学综述,2009,15(20):3095-3098. 被引量:12
  • 2Peters WA,Liu PY,Barrett RJ,et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix[J].Clin Onco,2000,18(8):1606-1613.
  • 3Eifel PJ.Chemoradiotherapy in the treatment of cervical cancer[J].Semin Radiat Onco,2006,3(16):177-185.
  • 4Aoki Y,Sasaki M,Watanabe M,et al.High-risk group in node-positive patients with stage ⅠB,ⅡA,and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation[J].Gynecol Onco,2000,77(3):305-309.
  • 5Yamada T,Ohsugi F,Irie T,et al.Extended intraarterial cisplatin infusion for treatment of gynecologic cancer after alteration of intrapelvic blood flow and implantation of a vascular access device[J].Cardiovasc Intervent Radio,1996,19(5):139-145.
  • 6Aoki Y,Tomita M,Sato T,et al.Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix[J].Semin Radiat Onco,2006,3(16):177-185.
  • 7季成萍,吴强,孙志华,赵一兵,邵衡华.年轻Ⅰb~Ⅱb期高危宫颈癌术前同步放化疗的疗效分析[J].医学研究生学报,2009,22(10):1056-1059. 被引量:9
  • 8王平,彭芝兰,张家文,刘辉,张崇淑,曹泽毅.子宫颈癌新辅助化疗中不同化疗途径的疗效比较[J].中华妇产科杂志,2005,40(4):227-230. 被引量:109

二级参考文献50

  • 1姜继勇,陈雪莲.青年人宫颈癌临床病理特征和预后的研究[J].临床肿瘤学杂志,2005,10(1):45-48. 被引量:6
  • 2张云霞,古扎丽努尔.阿不力孜.同步放化疗治疗中晚期宫颈癌366例临床分析[J].新疆医科大学学报,2006,29(1):46-47. 被引量:6
  • 3卢金利,杨芳.宫颈癌中顺铂放疗增敏的临床药代动力学机制[J].南方医科大学学报,2006,26(8):1170-1172. 被引量:10
  • 4Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer [ J ]. N Engl J Med, 1999,340 ( 15 ) : 1137-1143.
  • 5Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma[ J]. N Engl J Med, 1999,340( 15 ) : 1154-1161.
  • 6Jurado M, Martinez-Monge R, Garcia-Foncillas J, et al. Pilot study of concurrent cisplatin,5-fluorouracil,and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer [ J ]. Gynecol Oncol, 1999,74(1 ) :30-37.
  • 7Windschall A, Ott O J, Sane R,et al. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma[ J]. Strahlenther Onkol,2005,181 ( 8 ) :545-550.
  • 8Grigsby PW. Prospective phase I / Ⅱ study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy [ J ]. Int J Gynecol Cancer,2004,14 ( 5 ) : 860-864.
  • 9Miglietta L,Franzone P,Centurioni MG,et al. A phase Ⅱ trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer[ J]. Oncolngy,2006,70( 1 ) : 19-24.
  • 10Alberts DS, Gareia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix : an update [ J ]. Semin Oncol, 1998,18 ( 3 ) : 11-24.

共引文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部